Janux Therapeutics, Inc. 10-Q

Accession 0000950170-22-008984

Filing information

CIK: 0001817713
Report date: 2022-03-31
Filing date: 2022-05-10
Form: 10-Q
Primary document: janx-20220331.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.